CtrlK
Moderna
MRNA54
$34.30arrow_drop_down2.02%-$0.71
S&P500
MRNA54
$34.30
arrow_drop_down2.02%| Key Stats | |
|---|---|
| Open | $35.15 |
| Prev. Close | $35.01 |
| EPS | -9.28 |
| Dividend | Non-Dividend |
| Next Earnings Date | - |
| Dividend Yield % | - |
| Market Cap | $13.26B |
| PE Ratio | - |
| LOW | HIGH | |
|---|---|---|
| Day Range | 34.16 | 38.03 |
| 52 Week Range | 29.31 | 170.47 |
There's no data available for fundamentals
Stock Analysis
Stock Performance
MRNA-
US Tech-
US Market-
Moderna (MRNA) Statistics
Keep an eye on Moderna
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
How has Moderna (MRNA) stock's performance compared to its sector and the market over the past year?
Over the past year, Moderna (MRNA) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 18.46%, Moderna has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 31.78%, it has fallen short of the market average. This comparison highlights Moderna 's performance relative to both its sector and the overall market over the last year.
help
What is the PE ratio of Moderna (MRNA) stock?
The PE ratio for Moderna (MRNA) is currently not available. This could be due to a variety of factors such as the company not having positive earnings at the moment or recent updates not being reflected.
help
What is the EPS of Moderna (MRNA) stock?
The Earnings Per Share (EPS) for Moderna (MRNA), calculated on a diluted basis, is -$9.28. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help
What is the operating margin of Moderna (MRNA) stock?
The operating margin for Moderna (MRNA) is -128.99%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help
What is the EBITDA of Moderna (MRNA) stock?
The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Moderna (MRNA) is -$3.76B. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help
How much debt does Moderna (MRNA) have?
Moderna (MRNA) has a total debt of $747M. The net debt, which accounts for cash and cash equivalents against the total debt, is -$1.22B.